HPV vax uptake results "encouraging" for the UK
Financial incentives: to pay or not to pay?
AHA advises heart examination before ADHD treatment
The National Comprehensive Cancer Network (NCCN) has announced updates to the NCCN Clinical Practice Guidelines in Oncology
Docetaxel of value for metastatic breast cancer
Sevelamer could be worth it in hyperphosphataemia
Poor compliance with US infant vax schedule a cause for concern
News from AMCP
MR-guided ultrasound surgery of value in uterine leiomyoma
Otitis media guidelines underutilised in US
Neutropenic complications of chemotherapy costly
Mumps outbreak despite high vax coverage: waning protection?
ENHANCE fallout − coverage and prescribing in leading health plans
COPD exacerbations exasperate costs in Canada
Maternity disease management programme cost saving
Management of glucocorticoid-induced osteoporosis: rheum for improvement?
Rosiglitazone meta-analysis: full impact on prescribing yet to be felt
The use of sedative drugs for treating insomnia among elderly inpatients "remains common",
Stress incontinence worrying and costly for US women
Buprenorphine/naloxone reduces drug abuse, costs
Self-medication a potential health threat in Belgium
Elderly patients with acute coronary syndromes (ACS) are less likely to receive guideline-recommended treatment than their younger counterparts,
Medicaid claims data for the US state of Indiana appear to "substantially underrepresent true prenatal syphilis screening rates",
Temozolomide benefits offset cost in newly diagnosed glioblastoma
ICU patients with CAP have higher mortality and hospital lengths of stay (LOS) than ward patients,
Clear heads needed in 'chemobrain' debate
Health-related QOL (HRQOL) is influenced by type of insurance in younger men being treated for prostate cancer,
There is marked variation in psychostimulant prescribing to children within and between clinical specialities.
Bevacizumab plus paclitaxel/carboplatin is predicted to become the clinical gold-standard for advanced ovarian cancer in 2011,
Merck has initiated its assistance programme for treating schistosomiasis in school-aged African children
Malaria drug price cut to improve access.
The British Medical Association (BMA) has rejected a proposal that suggests that GPs should pay for unnecessary patient visits to ED.
The growing market for generic prescription drugs has become a formidable threat to branded pharmaceutical companies.